Home

Vojo Vukovic

CIK 1466794 · CHIEF MEDICAL OFFICER · last filed 2026-02-18

Vojo Vukovic is a CHIEF MEDICAL OFFICER who has filed 27 SEC Form 4 insider transactions across 3 companies since 2010. The most recent filing, for DCTH, was dated Feb 18, 2026. Across all open-market trades the lifetime net is +$370.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.78M

Companies

3

Total Filings

27

Lifetime Open-Market Net

$370.2K

Filer Profile

Reported Address
C/O SYNTA PHARMACEUTICALS CORP.
45 HARTWELL AVENUE
LEXINGTON, MA 02421
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DCTH CHIEF MEDICAL OFFICER 168,882 $16.48 $2.78M $268.8K 7 2026-02-18
Rein Therapeutics, Inc. (ALRN) Delisted Chief Medical Officer 3,750 $2.11 $7.9K $44.5K 7 2022-03-30
MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted SVP, Chief Medical Officer 35,249 — — $56.9K 13 2015-10-06

Recent Filings

27 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-02-18 DCTH Grant (A) — $0 EDGAR
2025-06-13 DCTH Exer (M) +42,000 $200.8K EDGAR
2025-02-07 DCTH Grant (A) — $0 EDGAR
2024-03-19 DCTH Grant (A) +26,882 $100.0K EDGAR
2024-02-14 DCTH Grant (A) — $0 EDGAR
2023-12-14 DCTH Buy (P) +40,000 $120.0K EDGAR
2023-11-20 DCTH Buy (P) +60,000 $148.8K EDGAR
2022-03-30 Rein Therapeutics, Inc. (ALRN) Delisted Grant (A) — $0 EDGAR
2022-03-24 Rein Therapeutics, Inc. (ALRN) Delisted Grant (A) — $0 EDGAR
2021-06-17 Rein Therapeutics, Inc. (ALRN) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 27
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.